| 英文別名： |
Ifosfamide;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-;2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide;A 4942;Asta Z 4942;Cyfos;Holoxan;Holoxan 1000;Ifex;Ifosfamid;Iphosphamid;Iphosphamid(e);Isoendoxan;Isofosfamide;Isophosphamide;Mitoxana;MJF 9325;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide;N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide;Naxamide;Z4942;N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide;3-(2-chloroethyl)-2-[(2-chloroethyl)-amino]-2-oxo-1,3,2-oxazaphosphorinane;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydrochloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide;Ifex N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide;ifosphamide;ilfosfamide;iphosphamide;rac-iphosphamide;N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide;I-Phosphamide;Ifsofamide;Ifosfamidum;Ifosfamida;isosfamide;Ifosfamidum [INN-Latin];Ifosfamida [INN-Spanish];ifomide;Z 4942;NSC109724;3-(2-Chloroethyl)-2-((2-chloroethyl);Ifosphamide;SCHEMBL4885;IFOSFAMIDE [INN];3778-73-2;NCI-CO1638;CCG-213464;IFOSFAMIDE [VANDF];CS-1424;CHEMBL1024;WLN: T6NPOTJ AM2G BO B2G;AB00513932-06;Ifosfamidum (INN-Latin);IFO-Cell;N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid;starbld0001221;SW197177-4;3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide;CCRIS 352;NCGC00179435-02;SR-05000002022-5;ISOPHOSPHAMIDE (IARC);N,N-BIS(BETA-CHLOROETHYL)-AMINO-N'-O-PROPYLENE-PHOSPHORIC ACID ESTER DIAMIDE;3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide;3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide;HMS3654B15;IFOSFAMIDE [USAN];MLS002154021;AB02316;MJF-9325;Iso Endoxan;IFOSFAMIDE [MART.];(S)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide;HMS3714H07;AB00513932_09;2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd;IFOSFAMIDE (MART.);HMS3374B08;HSDB 7023;Asta Z-4942;1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide;EN300-7476797;Z-4942;Seromida;Isophosphamide,(S);N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German];ISOPHOSPHAMIDE [IARC];IFOSFAMIDE (USP-RS);Prestwick3_000833;HMS2090M12;NSC-109724;2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine;1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide;IFOSFAMIDE [USP-RS];Ifosfamide, European Pharmacopoeia (EP) ... |
滬公網(wǎng)安備31011402010658號(hào) 
